Real-time enrollment status for this advanced melanoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:50 PM UTC
| NCT Number | NCT06264180 |
| Recruiting Status | Recruiting |
| Condition | Advanced Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Replimune Inc. |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of October 15, 2026: Clinical trial NCT06264180 is currently recruiting participants. This phase3 study for advanced melanoma is actively seeking new participants at 50 locations across the United States. The study is sponsored by Replimune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06264180 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06264180 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.